OncoTargets and Therapy (Apr 2021)
A Novel Circular RNA circCSPP1 Promotes Liver Cancer Progression by Sponging miR-1182
Abstract
Nan Jia, Zhe Song, Baosheng Chen, Jinsheng Cheng, Wenyong Zhou Department of General Surgery, CangZhou General Hospital, CangZhou, Hebei, 061001, People’s Republic of ChinaCorrespondence: Nan JiaDepartment of General Surgery, CangZhou General Hospital, No. 16 Xinhua West Road, CangZhou, Hebei, 061001, People’s Republic of ChinaTel +86-18031792208Email [email protected]: Aberrant circular RNA (circRNA) expression has been extensively discovered for its involvement in both the initiation and progression of various cancers. Through screening circRNA profile, we identified a novel circRNA has_circ_0001806, which is termed as circCSPP1 in liver cancer. In the present study, we aim to investigate the role of circCSPP1 in the progression of liver cancer.Methods: Fluorescence in situ hybridization (FISH) was used to detect the location of circCSPP1. Function studies including MTT, colony formation assay, transwell assay and flow cytometry were carried out to detect the malignant behaviour of circCSPP1 on liver cancer cells. Luciferase assay and RNA pull down were used to detect the interaction between miR-1182 and circCSPP1 as well as RAB15. Quantitative realtime (qPCR) and Western blot were performed to evaluate the RNA and protein expression, respectively.Results: CircCSPP1 knockdown inhibited the proliferation, migration and invasion while promoted apoptosis of liver cancer cells. Mechanically, we predicted and verified the target miR of circCSPP1 which is miR-1182. miR-1182 was capable of reversing the effect of circCSPP1 on liver cancer cells. Moreover, miR-1182 was found to also target RAB15 to participate in the regulation of cell phenotype.Discussion: Taken together, circCSPP1 promoted progression of liver cancer cells via sponging miR-1182 which may serve as a novel prognostic and therapeutic target for liver cancer.Keywords: circRNA, circCSPP1, liver cancer, miR-1182, RAB15
